368 related articles for article (PubMed ID: 23125415)
1. Integrins αvβ3 and α4β1 act as coreceptors for fractalkine, and the integrin-binding defective mutant of fractalkine is an antagonist of CX3CR1.
Fujita M; Takada YK; Takada Y
J Immunol; 2012 Dec; 189(12):5809-19. PubMed ID: 23125415
[TBL] [Abstract][Full Text] [Related]
2. The chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site.
Fujita M; Takada YK; Takada Y
PLoS One; 2014; 9(5):e96372. PubMed ID: 24789099
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the fractalkine chemokine domain. Basic amino acid residues differentially contribute to CX3CR1 binding, signaling, and cell adhesion.
Harrison JK; Fong AM; Swain PA; Chen S; Yu YR; Salafranca MN; Greenleaf WB; Imai T; Patel DD
J Biol Chem; 2001 Jun; 276(24):21632-41. PubMed ID: 11278650
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces integrin activation through direct binding to a newly identified binding site (site 2) in integrins αvβ3, α4β1, and α5β1.
Fujita M; Zhu K; Fujita CK; Zhao M; Lam KS; Kurth MJ; Takada YK; Takada Y
J Biol Chem; 2015 Jan; 290(1):259-71. PubMed ID: 25398877
[TBL] [Abstract][Full Text] [Related]
5. Stromal cell-derived factor-1 (CXCL12) activates integrins by direct binding to an allosteric ligand-binding site (site 2) of integrins without CXCR4.
Fujita M; Davari P; Takada YK; Takada Y
Biochem J; 2018 Feb; 475(4):723-732. PubMed ID: 29301984
[TBL] [Abstract][Full Text] [Related]
6. Direct integrin binding to insulin-like growth factor-2 through the C-domain is required for insulin-like growth factor receptor type 1 (IGF1R) signaling.
Cedano Prieto DM; Cheng Y; Chang CC; Yu J; Takada YK; Takada Y
PLoS One; 2017; 12(9):e0184285. PubMed ID: 28873464
[TBL] [Abstract][Full Text] [Related]
7. The binding of monomeric C-reactive protein (mCRP) to Integrins αvβ3 and α4β1 is related to its pro-inflammatory action.
Fujita M; Takada YK; Izumiya Y; Takada Y
PLoS One; 2014; 9(4):e93738. PubMed ID: 24695572
[TBL] [Abstract][Full Text] [Related]
8. Pro-inflammatory secretory phospholipase A2 type IIA binds to integrins alphavbeta3 and alpha4beta1 and induces proliferation of monocytic cells in an integrin-dependent manner.
Saegusa J; Akakura N; Wu CY; Hoogland C; Ma Z; Lam KS; Liu FT; Takada YK; Takada Y
J Biol Chem; 2008 Sep; 283(38):26107-15. PubMed ID: 18635536
[TBL] [Abstract][Full Text] [Related]
9. Viral macrophage inflammatory protein-II and fractalkine (CX3CL1) chimeras identify molecular determinants of affinity, efficacy, and selectivity at CX3CR1.
Davis CN; Zujovic V; Harrison JK
Mol Pharmacol; 2004 Dec; 66(6):1431-9. PubMed ID: 15361546
[TBL] [Abstract][Full Text] [Related]
10. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion.
Imai T; Hieshima K; Haskell C; Baba M; Nagira M; Nishimura M; Kakizaki M; Takagi S; Nomiyama H; Schall TJ; Yoshie O
Cell; 1997 Nov; 91(4):521-30. PubMed ID: 9390561
[TBL] [Abstract][Full Text] [Related]
11. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation.
Echigo T; Hasegawa M; Shimada Y; Takehara K; Sato S
J Allergy Clin Immunol; 2004 May; 113(5):940-8. PubMed ID: 15131578
[TBL] [Abstract][Full Text] [Related]
12. An integrin binding-defective mutant of insulin-like growth factor-1 (R36E/R37E IGF1) acts as a dominant-negative antagonist of the IGF1 receptor (IGF1R) and suppresses tumorigenesis but still binds to IGF1R.
Fujita M; Ieguchi K; Cedano-Prieto DM; Fong A; Wilkerson C; Chen JQ; Wu M; Lo SH; Cheung AT; Wilson MD; Cardiff RD; Borowsky AD; Takada YK; Takada Y
J Biol Chem; 2013 Jul; 288(27):19593-603. PubMed ID: 23696648
[TBL] [Abstract][Full Text] [Related]
13. Direct binding of the EGF-like domain of neuregulin-1 to integrins ({alpha}v{beta}3 and {alpha}6{beta}4) is involved in neuregulin-1/ErbB signaling.
Ieguchi K; Fujita M; Ma Z; Davari P; Taniguchi Y; Sekiguchi K; Wang B; Takada YK; Takada Y
J Biol Chem; 2010 Oct; 285(41):31388-98. PubMed ID: 20682778
[TBL] [Abstract][Full Text] [Related]
14. The CX3C chemokine fractalkine mediates platelet adhesion via the von Willebrand receptor glycoprotein Ib.
Meyer dos Santos S; Klinkhardt U; Scholich K; Nelson K; Monsefi N; Deckmyn H; Kuczka K; Zorn A; Harder S
Blood; 2011 May; 117(18):4999-5008. PubMed ID: 21398580
[TBL] [Abstract][Full Text] [Related]
15. Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction. Rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation.
Haskell CA; Cleary MD; Charo IF
J Biol Chem; 1999 Apr; 274(15):10053-8. PubMed ID: 10187784
[TBL] [Abstract][Full Text] [Related]
16. Fractalkine and its receptor mediate extracellular matrix accumulation in diabetic nephropathy in mice.
Song KH; Park J; Park JH; Natarajan R; Ha H
Diabetologia; 2013 Jul; 56(7):1661-9. PubMed ID: 23604552
[TBL] [Abstract][Full Text] [Related]
17. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
18. Fractalkine functions as a chemoattractant for osteoarthritis synovial fibroblasts and stimulates phosphorylation of mitogen-activated protein kinases and Akt.
Klosowska K; Volin MV; Huynh N; Chong KK; Halloran MM; Woods JM
Clin Exp Immunol; 2009 May; 156(2):312-9. PubMed ID: 19302240
[TBL] [Abstract][Full Text] [Related]
19. The direct binding of insulin-like growth factor-1 (IGF-1) to integrin alphavbeta3 is involved in IGF-1 signaling.
Saegusa J; Yamaji S; Ieguchi K; Wu CY; Lam KS; Liu FT; Takada YK; Takada Y
J Biol Chem; 2009 Sep; 284(36):24106-14. PubMed ID: 19578119
[TBL] [Abstract][Full Text] [Related]
20. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow.
Fong AM; Robinson LA; Steeber DA; Tedder TF; Yoshie O; Imai T; Patel DD
J Exp Med; 1998 Oct; 188(8):1413-9. PubMed ID: 9782118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]